Association of Intensive Lifestyle Intervention for Type 2 Diabetes With Labor Market Outcomes

Author:

Huckfeldt Peter J.1,Yu Jeffrey C.234,O’Leary Paul K.5,Harada Ann S. M.26,Pajewski Nicholas M.7,Frenier Chris18,Espeland Mark A.79,Peters Anne10,Bancks Michael P.11,Seabury Seth A.23,Goldman Dana P.26

Affiliation:

1. Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis

2. Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles

3. Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles

4. Alexion Pharmaceuticals, Ltd, Boston, Massachusetts

5. Office of Retirement and Disability Policy, Social Security Administration

6. Sol Price School of Public Policy, University of Southern California, Los Angeles

7. Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina

8. Yale University School of Public Health, New Haven, Connecticut

9. Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina

10. Keck School of Medicine of the University of Southern California, Los Angeles

11. Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina

Abstract

ImportanceAn intensive lifestyle intervention (ILI) has been shown to improve diabetes management and physical function. These benefits could lead to better labor market outcomes, but this has not been previously studied.ObjectiveTo estimate the association of an ILI for weight loss in type 2 diabetes with employment, earnings, and disability benefit receipt during and after the intervention.Design, Setting, and ParticipantsThis cohort study included participants with type 2 diabetes and overweight or obesity and compared an ILI with a control condition of diabetes support and education. Data for the original trial were accrued from August 22, 2001, to September 14, 2012. Trial data were linked with Social Security Administration records to investigate whether, relative to the control group, the ILI was associated with improvements in labor market outcomes during and after the intervention period. Difference-in-differences models estimating relative changes in employment, earnings, and disability benefit receipt between the ILI and control groups were used, accounting for prerandomization differences in outcomes for linked participants. Outcome data were analyzed from July 13, 2020, to May 17, 2023.ExposureThe ILI consisted of sessions with lifestyle counselors, dieticians, exercise specialists, and behavioral therapists on a weekly basis in the first 6 months, decreasing to a monthly basis by the fourth year, designed to achieve and maintain at least 7% weight loss. The control group received group-based diabetes education sessions 3 times annually during the first 4 years, with 1 annual session thereafter.Main Outcomes and MeasuresEmployment and receipt of federal disability benefits (Supplemental Security Income and Social Security Disability Insurance), earnings, and disability benefit payments from 1994 through 2018.ResultsA total of 3091 trial participants were linked with Social Security Administration data (60.1% of 5145 participants initially randomized and 97.0% of 3188 of participants consenting to linkage). Among the 3091 with fully linked data, 1836 (59.4%) were women, and mean (SD) age was 58.4 (6.5) years. Baseline clinical and demographic characteristics were similar between linked participants in the ILI and control groups. Employment increased by 2.9 (95% CI, 0.3-5.5) percentage points for the ILI group relative to controls (P = .03) with no significant relative change in disability benefit receipt (−0.9 [95% CI, −2.1 to 0.3] percentage points; P = .13).Conclusions and RelevanceThe findings of this cohort study suggest that an ILI to prevent the progression and complications of type 2 diabetes was associated with higher levels of employment. Labor market productivity should be considered when evaluating interventions to manage chronic diseases.

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3